Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
D000230:Adenocarcinoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use*; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005472:Fluorouracil / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*; D011344:Procarbazine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001565:Benzoates; D011344:Procarbazine; D005472:Fluorouracil